65,437 trials
Uterine Cancer · Cervical Cancer
Primary: Dosimetric Comparison of Proton Beam Treatment With 3-dimensional Conformal Radiation Therapy (3DCRT) and Intensity Modulated Radiation Therapy (IMRT) — 455.0; 149.0…
Cognitive Decline
Primary: Percentage of Trials Correct On Working Memory Test — 87.69; 91.57; 88.01; 91.68 percentage of correct trials — p=>0.05
General Anesthesia
Primary: Success Rate of General Anesthesia Induction — 253; 128 Participants — p=<0.001
Sleep Disturbance
Primary: Recruitment Rate - Acceptability of New Intervention for Cancer-Related Sleep Disturbances — 30 Participants
Hearing
Primary: International Outcome Inventory for Hearing Aids (IOI-HA) Survey Results — 25.5; 26.6 score on a scale
Breast Neoplasm · Primary Prevention · Risk Factors
Primary: Behavioral BC Risk With an Educational Intervention for Prevention — 8.10; 8.15 units on a scale
Primary Sjogren Syndrome
Primary: Least Squares Mean Change From Baseline in ESSDAI Score at Week 24 — -6.39; -5.64; -6.93; -8.30 Scores on a scale — p=0.5161
Ulcerative Colitis
Primary: Percentage of Participants Who Achieved Clinical Remission at Week 12 — 0; 6.7; 26.3 Percentage of participants
COPD · COPD Exacerbation · COPD Exacerbation Acute
Primary: Change in St. George Respiratory Questionnaire (SGRQ) Scores — 39.02; 45.06 score on a scale
Renal Cell Cancer
Primary: Progression Free Survival (PFS) as Assessed by Blinded Independent Central Review (BICR) in Programmed Death-Ligand 1 (PD-L1) Positive Participants — 13.8; 7.2 Months…
Venous Thromboembolism
Primary: Percentage of Participants With Composite of Major and Clinically Relevant Non-Major (CRNM) Bleeding — 1.3; 1.4 percentage of participants
Sickle Cell Disease · Sickle-Cell; Hemoglobin Disease, Thalassemia · Sickle Cell-beta-thalassemia
Primary: Clearance (CL/F) — 3.61 L/hr
Health Care Utilization · Vaccine Preventable Disease
Primary: Number of Participants Who Completed an Adolescent Well-care Visit — 43; 56; 55 Participants — p=0.165
Arterial Occlusive Diseases · Atherosclerosis · Vascular Diseases
Primary: Number of Subjects With Primary Patency at 12 Months Post-procedure — 337; 165 Participants — p=0.0077
Cavity · Cavities of Teeth
Primary: Marginal Staining: World Dental Federation (FDI) Criteria - Baseline — 18; 18; 0; 0 Participants